We are live on ! Find out more
CTMX icon

CytomX Therapeutics
CTMX

60 hedge funds and large institutions have $193M invested in CytomX Therapeutics in 2016 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 28 increasing their positions, 6 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

367% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 6

200% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 6

22% more funds holding

Funds holding: 49 → 60 (+11)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

15% less capital invested

Capital invested by funds: $226M → $193M (-$33.5M)

Holders
60
Holders Change
+11
Holders Change %
+22.45%
% of All Funds
1.6%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
18
Increased
28
Reduced
6
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BA
BlackRock Advisors
Delaware
+$6.16M
2
TCM
Tekla Capital Management
Massachusetts
+$4.88M
3
BFA
BlackRock Fund Advisors
California
+$3.77M
4
PAG
Private Advisor Group
New Jersey
+$2.51M
5
State Street
State Street
Massachusetts
+$1.86M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$9.66M
2
CPI
Canaan Partners IX
California
-$7.3M
3
CC
Casdin Capital
New York
-$990K
4
GC
Globeflex Capital
California
-$761K
5
EI
EAM Investors
California
-$591K
Name Holding Trade Value Shares
Change 		Change in
Stake
ROTUOC
26
Regents of the University of California
California
$729K +$814K +71,366 New
VIA
27
Vident Investment Advisory
Georgia
$692K -$69.7K -6,109 -8%
CS
28
Candriam SCA
Luxembourg
$684K +$285K +25,000 +60%
TCIM
29
TIAA CREF Investment Management
New York
$678K +$561K +49,158 +286%
VM
30
VHCP Management
New York
$656K – – –
EA
31
Emerald Acquisition
Washington
$446K +$498K +43,684 New
California State Teachers Retirement System (CalSTRS)
32
California State Teachers Retirement System (CalSTRS)
California
$438K +$303K +26,607 +164%
Charles Schwab
33
Charles Schwab
California
$427K +$214K +18,794 +82%
TA
34
Teachers Advisors
New York
$335K +$286K +25,089 +327%
Swiss National Bank
35
Swiss National Bank
Switzerland
$230K +$257K +22,500 New
New York State Common Retirement Fund
36
New York State Common Retirement Fund
New York
$213K +$155K +13,600 +186%
MLICM
37
Metropolitan Life Insurance Company (MetLife)
New York
$175K +$196K +17,176 New
Manulife (Manufacturers Life Insurance)
38
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$161K +$113K +9,946 +171%
T. Rowe Price Associates
39
T. Rowe Price Associates
Maryland
$153K +$171K +15,000 New
RhumbLine Advisers
40
RhumbLine Advisers
Massachusetts
$152K +$170K +14,926 New
Millennium Management
41
Millennium Management
New York
$145K +$162K +14,195 New
CS
42
Credit Suisse
Switzerland
$142K +$158K +13,877 New
NFA
43
Nationwide Fund Advisors
Ohio
$132K +$87.7K +7,688 +147%
AIG
44
American International Group
New York
$120K +$83.6K +7,333 +166%
HP
45
Harbourvest Partners
Massachusetts
$102K +$114K +10,000 New
BlackRock
46
BlackRock
New York
$77K +$85.3K +7,479 +7,056%
Legal & General Group
47
Legal & General Group
United Kingdom
$36K +$41.7K +3,655 New
Bank of America
48
Bank of America
North Carolina
$33K +$16K +1,405 +80%
MCM
49
Manchester Capital Management
Vermont
$33K +$36.9K +3,239 New
Deutsche Bank
50
Deutsche Bank
Germany
$31K +$22.5K +1,970 +168%
1
2
3

CTMX Hedge Fund Activity: Q2 2016 in Review

60 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in CytomX Therapeutics (CTMX) for Q2 2016, worth a combined $193M — down 15% from $226M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new CTMX positions and 6 closed out — a net gain of 12 holders — while 28 added to existing stakes and 6 trimmed.

The largest buyer was BlackRock Advisors, adding an estimated $6.16M. The largest seller was Wellington Management Group, exiting entirely with an estimated $9.66M sold.

  • 60 institutional investors held CytomX Therapeutics (CTMX) as of Q2 2016, up from 49 in Q1 2016.
  • Funds reported $193M of CytomX Therapeutics stock for Q2 2016, down 15% quarter-over-quarter.
  • 18 funds opened new CytomX Therapeutics positions in Q2 2016 and 6 closed out, a net change of +12 holders.
  • The largest CytomX Therapeutics buyer in Q2 2016 was BlackRock Advisors, an estimated $6.16M added.
  • The largest CytomX Therapeutics seller in Q2 2016 was Wellington Management Group, an estimated $9.66M sold.

Based on aggregated 13F filings for Q2 2016.